Article: Now, a drug that can reduce heart attack damage

Washington, July. 25 -- Scientists have identified that a new drug that has the potential to dramatically reduce heart muscle damage after a heart attack and may lead to significantly improved patient outcomes.

Researchers at University of New South Wales say that pre-clinical trials have shown that the drug, known as Dz13, specifically targets and neutralises the gene responsible for inflammation and muscle death in the aftermath of a heart attack.

The drug also reduces incidental cell and tissue death resulting from life-saving interventions such as balloon angioplasty and stent placements used to open blocked arteries, or from the delivery of clot-busting drugs.

Significantly, the drug ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!